Revitalizing FDA’s Office Of Regulatory Affairs Means ‘Buying’ Some Expertise
This article was originally published in The Gray Sheet
Executive Summary
After years of shrinking resources and workforce attrition, FDA's Office of Regulatory Affairs plans to aggressively recruit new staff to meet the emerging challenges of more complex products and overseas manufacturing